Disease / condition

Partially Edentulous Patients,Bone Crest of at Least 10 mm Length and 6 mm Width,Patients of at Least 18 Years Old,Good General Health (ASAS Type 1-2 Suitable for Oral Surgery) clinical trials

Free access to 1 studies·1+ countries·Updated daily1 recruiting
1
Total trials
1+
Countries
1+
Sponsors
1
Recruiting
By phase
N/A1
By status
Recruiting1
Top countries
Spain1
Top sponsors
Universitat Intern...1
Recent trials
Latest clinical trials for Partially Edentulous Patients,Bone Crest of at Least 10 mm Length and 6 mm Width,Patients of at Least 18 Years Old,Good General Health (ASAS Type 1-2 Suitable for Oral Surgery)
NCT06417788Recruiting
Dynamic Guided Implant Surgery VS Static Guided Surgery.
Universitat Internacional de C...Spain
About this record

Access comprehensive clinical trial information for Partially Edentulous Patients,Bone Crest of at Least 10 mm Length and 6 mm Width,Patients of at Least 18 Years Old,Good General Health (ASAS Type 1-2 Suitable for Oral Surgery) through Pure Global AI's free database. This collection includes 1 clinical trials across multiple phases including N/A. Currently, 1 trials are actively recruiting participants.

Research for Partially Edentulous Patients,Bone Crest of at Least 10 mm Length and 6 mm Width,Patients of at Least 18 Years Old,Good General Health (ASAS Type 1-2 Suitable for Oral Surgery) is being conducted in Spain and more. Leading sponsors include Universitat Internacional de Catalunya. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1 clinical trials studying Partially Edentulous Patients,Bone Crest of at Least 10 mm Length and 6 mm Width,Patients of at Least 18 Years Old,Good General Health (ASAS Type 1-2 Suitable for Oral Surgery), aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 1+ countries.

Top research sponsors include Universitat Internacional de Catalunya, among others.